source
- Study finds nearly 40% of FDA advisory panels include reps linked to pharma-funded advocacy groupsA new analysis published in Health Affairs Scholar examined FDA advisory committee meetings over the past 20 years and found that almost 40% featured a patient or consumer representative with activ…
- iOnctura’s roginolisib shows encouraging phase 1 results in metastatic uveal melanomaiOnctura, a spinout of Merck KGaA, reported data from a two‑part phase 1 trial of its PI3K delta inhibitor roginolisib in patients with advanced solid and hematologic cancers, including a cohort of…